Whilst ozempic is the most well known diabetes turned weight loss peptide, there have been a number of products going through trials over the last few years.
Tirzepatide and Mounjaro are the 2 most well known but due to the several year process to achieve final approval even these 2 are what you could call old technology.
Retratrutide is obviously the most popular and well known of the latest generation of more effective weight loss peptides but there's also a product out of China that's been going through the approval process concurrently with Retratrutide, it's called mazdutide.
The product is also a multi approach glp similar to Retratrutide and results have been similar, with both Retratrutide and mazdutide showing significantly better results than Mounjaro and ozempic.
This provides an option of switching between both products to avoid having to increase the dosage of one product too much.
I.e. if after 3 or 4 months of Retratrutide you have increased dosage from 2mg to 6mg as your body adjusted, rather than increasing to 8mg you switch to an initial low dose of mazdutide and utilise until dosage increases too much then swap back to Retratrutide and start again at low initial dose as your body has reset.
This is a cheaper and more effective solution for long term use.
